[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f9prAmz1wYJ4aBRu2bYcWEEh63HwfAj0MKnRQrDzSKXo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Pamukkale University",[4],303,false,41,0,25737,5,275,[14,17,20,22,24,26,28,31],{"name":15,"count":16},"Stroke",10,{"name":18,"count":19},"Multiple Sclerosis",6,{"name":21,"count":19},"Pain",{"name":23,"count":19},"Urinary Bladder, Overactive",{"name":25,"count":11},"Hand Injuries",{"name":27,"count":11},"Cerebral Palsy",{"name":29,"count":30},"Fatigue",4,{"name":32,"count":30},"Flexibility",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT07415278","INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION","2023-10-30","Fluticasone propionate nasal spray",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05215197","Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation","2025-12-01","intracochlear platelet rich fibrin administration",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07473232","Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)","2026-06-30","Autologous Platelet-Rich Plasma",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,82,100,122,147,165,256,285,309,336,354,372,390,416,434,458,476,503,521,539,624,662,689,707,734,752,770,799,817,835,860,887,905,930,956,974],{"intervention":38,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":80},{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":58,"soonestReadout":37},[70],{"nctId":35,"briefTitle":36,"status":71,"phases":72,"primaryCompletion":37,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":78},"ACTIVE_NOT_RECRUITING",[54],"2026-10-30","2022-12-01",61,[77],"Allergic Rhinitis",[38,79],"Fluticasone propionate-azelastine nasal spray",{"trials":81,"activeCount":9},[],{"intervention":79,"totalTrials":58,"cells":83},{"EARLY_PHASE1":84,"PHASE1":86,"PHASE2":88,"PHASE3":90,"PHASE4":92,"NA":98},{"trials":85,"activeCount":9},[],{"trials":87,"activeCount":9},[],{"trials":89,"activeCount":9},[],{"trials":91,"activeCount":9},[],{"trials":93,"activeCount":58,"soonestReadout":37},[94],{"nctId":35,"briefTitle":36,"status":71,"phases":95,"primaryCompletion":37,"completion":73,"start":74,"enrollment":75,"conditions":96,"interventions":97},[54],[77],[38,79],{"trials":99,"activeCount":9},[],{"intervention":43,"totalTrials":58,"cells":101},{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":112},{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"trials":107,"activeCount":9},[],{"trials":109,"activeCount":9},[],{"trials":111,"activeCount":9},[],{"trials":113,"activeCount":58,"soonestReadout":42},[114],{"nctId":40,"briefTitle":41,"status":115,"phases":116,"primaryCompletion":42,"completion":117,"start":118,"enrollment":16,"conditions":119,"interventions":121},"RECRUITING",[55],"2025-12-20","2022-01-31",[120],"Hearing Loss, Sensorineural",[43],{"intervention":48,"totalTrials":58,"cells":123},{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":132,"NA":134},{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[],{"trials":133,"activeCount":9},[],{"trials":135,"activeCount":58,"soonestReadout":47},[136],{"nctId":45,"briefTitle":46,"status":137,"phases":138,"primaryCompletion":47,"completion":47,"start":139,"enrollment":140,"conditions":141,"interventions":145},"NOT_YET_RECRUITING",[55],"2026-04-01",60,[142,143,144],"Knee Arthritis Osteoarthritis","Platelet Rich Plasma Injection","Conditioned Serum",[48,146],"Conditioned serum",{"intervention":146,"totalTrials":58,"cells":148},{"EARLY_PHASE1":149,"PHASE1":151,"PHASE2":153,"PHASE3":155,"PHASE4":157,"NA":159},{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[],{"trials":156,"activeCount":9},[],{"trials":158,"activeCount":9},[],{"trials":160,"activeCount":58,"soonestReadout":47},[161],{"nctId":45,"briefTitle":46,"status":137,"phases":162,"primaryCompletion":47,"completion":47,"start":139,"enrollment":140,"conditions":163,"interventions":164},[55],[142,143,144],[48,146],{"intervention":166,"totalTrials":167,"cells":168},"Dexketoprofen",7,{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":177,"NA":254},{"trials":170,"activeCount":9},[],{"trials":172,"activeCount":9},[],{"trials":174,"activeCount":9},[],{"trials":176,"activeCount":9},[],{"trials":178,"activeCount":9},[179,191,201,209,222,231,244],{"nctId":180,"briefTitle":181,"status":182,"phases":183,"primaryCompletion":184,"completion":184,"start":185,"enrollment":186,"conditions":187,"interventions":189},"NCT03122314","Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain","COMPLETED",[54],"2016-09","2015-08",200,[188],"Musculoskeletal Pain",[190,166],"Paracetamol",{"nctId":192,"briefTitle":193,"status":182,"phases":194,"primaryCompletion":195,"completion":196,"start":197,"enrollment":186,"conditions":198,"interventions":200},"NCT01730326","Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack",[54],"2012-07","2012-11","2012-03",[199],"Acute Migraine",[190,166],{"nctId":202,"briefTitle":203,"status":182,"phases":204,"primaryCompletion":205,"completion":205,"start":206,"enrollment":186,"conditions":207,"interventions":208},"NCT03428503","Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain",[54],"2016-12","2015-12",[188],[190,166],{"nctId":210,"briefTitle":211,"status":182,"phases":212,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":218},"NCT01422291","IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain",[54],"2011-07","2011-01",120,[217],"Low Back Pain",[219,220,166,221],"paracetamol","morphine","Paracetamole",{"nctId":223,"briefTitle":224,"status":182,"phases":225,"primaryCompletion":226,"completion":226,"start":227,"enrollment":186,"conditions":228,"interventions":230},"NCT03768882","Comparison of the Efficacy of Intravenous Dexketoprofen and Paracetamol in the Treatment of Sore Throat",[54],"2018-07-30","2017-12-01",[229],"Sore Throat",[219,166],{"nctId":232,"briefTitle":233,"status":234,"phases":235,"primaryCompletion":236,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT04372264","Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache","UNKNOWN",[54],"2020-05-29","2020-12-29","2018-10-15",210,[241],"Headache, Migraine",[190,166,243],"Ibuprofen",{"nctId":245,"briefTitle":246,"status":182,"phases":247,"primaryCompletion":248,"completion":249,"start":250,"enrollment":239,"conditions":251,"interventions":253},"NCT04609254","Paracetamol, Dexketoprofen and Ibuprofen In Non-Traumatic Acute Low Back Pain",[54],"2020-04-15","2020-09-15","2018-12-15",[252],"Low Back Pain, Mechanical",[190,166,243],{"trials":255,"activeCount":9},[],{"intervention":220,"totalTrials":257,"cells":258},2,{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":283},{"trials":260,"activeCount":9},[],{"trials":262,"activeCount":9},[],{"trials":264,"activeCount":9},[],{"trials":266,"activeCount":9},[],{"trials":268,"activeCount":9},[269,279],{"nctId":270,"briefTitle":271,"status":182,"phases":272,"primaryCompletion":273,"completion":273,"start":214,"enrollment":274,"conditions":275,"interventions":277},"NCT01318187","Intravenous Paracetamol or Morphine for the Treatment of Acute Flank Pain",[54],"2011-03",73,[276],"Urolithiasis",[219,220,190,190,278],"Morphine",{"nctId":210,"briefTitle":211,"status":182,"phases":280,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":281,"interventions":282},[54],[217],[219,220,166,221],{"trials":284,"activeCount":9},[],{"intervention":286,"totalTrials":58,"cells":287},"Zolmitriptan",{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":307},{"trials":289,"activeCount":9},[],{"trials":291,"activeCount":9},[],{"trials":293,"activeCount":9},[],{"trials":295,"activeCount":9},[],{"trials":297,"activeCount":9},[298],{"nctId":299,"briefTitle":300,"status":182,"phases":301,"primaryCompletion":205,"completion":302,"start":303,"enrollment":186,"conditions":304,"interventions":306},"NCT03145467","Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department",[54],"2017-03","2016-01",[305],"Acute Migraine Headache",[190,286],{"trials":308,"activeCount":9},[],{"intervention":310,"totalTrials":58,"cells":311},"esomeprazole",{"EARLY_PHASE1":312,"PHASE1":314,"PHASE2":316,"PHASE3":318,"PHASE4":320,"NA":334},{"trials":313,"activeCount":9},[],{"trials":315,"activeCount":9},[],{"trials":317,"activeCount":9},[],{"trials":319,"activeCount":9},[],{"trials":321,"activeCount":9},[322],{"nctId":323,"briefTitle":324,"status":182,"phases":325,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":329,"interventions":331},"NCT02197143","A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain",[54],"2014-07","2013-03",286,[330],"Dyspepsia",[310,332,333],"Ranitidine","hydrotalcid",{"trials":335,"activeCount":9},[],{"intervention":332,"totalTrials":58,"cells":337},{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":346,"NA":352},{"trials":339,"activeCount":9},[],{"trials":341,"activeCount":9},[],{"trials":343,"activeCount":9},[],{"trials":345,"activeCount":9},[],{"trials":347,"activeCount":9},[348],{"nctId":323,"briefTitle":324,"status":182,"phases":349,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":350,"interventions":351},[54],[330],[310,332,333],{"trials":353,"activeCount":9},[],{"intervention":333,"totalTrials":58,"cells":355},{"EARLY_PHASE1":356,"PHASE1":358,"PHASE2":360,"PHASE3":362,"PHASE4":364,"NA":370},{"trials":357,"activeCount":9},[],{"trials":359,"activeCount":9},[],{"trials":361,"activeCount":9},[],{"trials":363,"activeCount":9},[],{"trials":365,"activeCount":9},[366],{"nctId":323,"briefTitle":324,"status":182,"phases":367,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":368,"interventions":369},[54],[330],[310,332,333],{"trials":371,"activeCount":9},[],{"intervention":221,"totalTrials":58,"cells":373},{"EARLY_PHASE1":374,"PHASE1":376,"PHASE2":378,"PHASE3":380,"PHASE4":382,"NA":388},{"trials":375,"activeCount":9},[],{"trials":377,"activeCount":9},[],{"trials":379,"activeCount":9},[],{"trials":381,"activeCount":9},[],{"trials":383,"activeCount":9},[384],{"nctId":210,"briefTitle":211,"status":182,"phases":385,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":386,"interventions":387},[54],[217],[219,220,166,221],{"trials":389,"activeCount":9},[],{"intervention":391,"totalTrials":58,"cells":392},"Dimenhydrinate",{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":399,"PHASE4":401,"NA":414},{"trials":394,"activeCount":9},[],{"trials":396,"activeCount":9},[],{"trials":398,"activeCount":9},[],{"trials":400,"activeCount":9},[],{"trials":402,"activeCount":9},[403],{"nctId":404,"briefTitle":405,"status":182,"phases":406,"primaryCompletion":407,"completion":407,"start":196,"enrollment":186,"conditions":408,"interventions":412},"NCT02253524","Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo",[54],"2013-05",[409,410,411],"Nausea","Vomiting","Vertigo",[391,413],"Metoclopramide",{"trials":415,"activeCount":9},[],{"intervention":413,"totalTrials":58,"cells":417},{"EARLY_PHASE1":418,"PHASE1":420,"PHASE2":422,"PHASE3":424,"PHASE4":426,"NA":432},{"trials":419,"activeCount":9},[],{"trials":421,"activeCount":9},[],{"trials":423,"activeCount":9},[],{"trials":425,"activeCount":9},[],{"trials":427,"activeCount":9},[428],{"nctId":404,"briefTitle":405,"status":182,"phases":429,"primaryCompletion":407,"completion":407,"start":196,"enrollment":186,"conditions":430,"interventions":431},[54],[409,410,411],[391,413],{"trials":433,"activeCount":9},[],{"intervention":435,"totalTrials":58,"cells":436},"Piroxicam",{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":443,"PHASE4":445,"NA":456},{"trials":438,"activeCount":9},[],{"trials":440,"activeCount":9},[],{"trials":442,"activeCount":9},[],{"trials":444,"activeCount":9},[],{"trials":446,"activeCount":9},[447],{"nctId":448,"briefTitle":449,"status":182,"phases":450,"primaryCompletion":326,"completion":326,"start":407,"enrollment":451,"conditions":452,"interventions":454},"NCT02253446","A Comparison of Analgesic İmpacts of Piroxicam and Diclofenac Sodium in the Treatment of Primary Dysmenorrhea",[54],400,[453],"Primary Dysmenorrhea",[435,455],"Diclofenac Sodium",{"trials":457,"activeCount":9},[],{"intervention":455,"totalTrials":58,"cells":459},{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":466,"PHASE4":468,"NA":474},{"trials":461,"activeCount":9},[],{"trials":463,"activeCount":9},[],{"trials":465,"activeCount":9},[],{"trials":467,"activeCount":9},[],{"trials":469,"activeCount":9},[470],{"nctId":448,"briefTitle":449,"status":182,"phases":471,"primaryCompletion":326,"completion":326,"start":407,"enrollment":451,"conditions":472,"interventions":473},[54],[453],[435,455],{"trials":475,"activeCount":9},[],{"intervention":477,"totalTrials":58,"cells":478},"Alginate",{"EARLY_PHASE1":479,"PHASE1":481,"PHASE2":483,"PHASE3":485,"PHASE4":487,"NA":501},{"trials":480,"activeCount":9},[],{"trials":482,"activeCount":9},[],{"trials":484,"activeCount":9},[],{"trials":486,"activeCount":9},[],{"trials":488,"activeCount":9},[489],{"nctId":490,"briefTitle":491,"status":182,"phases":492,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":497,"interventions":498},"NCT03635372","A Comparison of Effectiveness of Oral Sucrolfate, Alginate and Hydrotalcide in Dispeptic Pain Treatment",[54],"2017-10-22","2017-11-25","2017-06-20",300,[330],[477,499,500],"Sucralfate","Hydrotalcite",{"trials":502,"activeCount":9},[],{"intervention":499,"totalTrials":58,"cells":504},{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":513,"NA":519},{"trials":506,"activeCount":9},[],{"trials":508,"activeCount":9},[],{"trials":510,"activeCount":9},[],{"trials":512,"activeCount":9},[],{"trials":514,"activeCount":9},[515],{"nctId":490,"briefTitle":491,"status":182,"phases":516,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":517,"interventions":518},[54],[330],[477,499,500],{"trials":520,"activeCount":9},[],{"intervention":500,"totalTrials":58,"cells":522},{"EARLY_PHASE1":523,"PHASE1":525,"PHASE2":527,"PHASE3":529,"PHASE4":531,"NA":537},{"trials":524,"activeCount":9},[],{"trials":526,"activeCount":9},[],{"trials":528,"activeCount":9},[],{"trials":530,"activeCount":9},[],{"trials":532,"activeCount":9},[533],{"nctId":490,"briefTitle":491,"status":182,"phases":534,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":535,"interventions":536},[54],[330],[477,499,500],{"trials":538,"activeCount":9},[],{"intervention":190,"totalTrials":540,"cells":541},13,{"EARLY_PHASE1":542,"PHASE1":544,"PHASE2":546,"PHASE3":548,"PHASE4":550,"NA":612},{"trials":543,"activeCount":9},[],{"trials":545,"activeCount":9},[],{"trials":547,"activeCount":9},[],{"trials":549,"activeCount":9},[],{"trials":551,"activeCount":9},[552,556,560,564,568,577,581,585,594,598,602,606],{"nctId":270,"briefTitle":271,"status":182,"phases":553,"primaryCompletion":273,"completion":273,"start":214,"enrollment":274,"conditions":554,"interventions":555},[54],[276],[219,220,190,190,278],{"nctId":180,"briefTitle":181,"status":182,"phases":557,"primaryCompletion":184,"completion":184,"start":185,"enrollment":186,"conditions":558,"interventions":559},[54],[188],[190,166],{"nctId":299,"briefTitle":300,"status":182,"phases":561,"primaryCompletion":205,"completion":302,"start":303,"enrollment":186,"conditions":562,"interventions":563},[54],[305],[190,286],{"nctId":192,"briefTitle":193,"status":182,"phases":565,"primaryCompletion":195,"completion":196,"start":197,"enrollment":186,"conditions":566,"interventions":567},[54],[199],[190,166],{"nctId":569,"briefTitle":570,"status":234,"phases":571,"primaryCompletion":572,"completion":184,"start":573,"enrollment":215,"conditions":574,"interventions":576},"NCT02777320","Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department",[54],"2016-08","2016-03",[575],"Sciatica",[219,243],{"nctId":202,"briefTitle":203,"status":182,"phases":578,"primaryCompletion":205,"completion":205,"start":206,"enrollment":186,"conditions":579,"interventions":580},[54],[188],[190,166],{"nctId":210,"briefTitle":211,"status":182,"phases":582,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":583,"interventions":584},[54],[217],[219,220,166,221],{"nctId":586,"briefTitle":587,"status":182,"phases":588,"primaryCompletion":589,"completion":589,"start":590,"enrollment":186,"conditions":591,"interventions":593},"NCT03918135","Comparison of the Efficacy of Intravenous Paracetamol and Ibuprofen in the Treatment of Fever Due to Upper Respiratory Tract Infection",[54],"2020-01-01","2019-01-01",[592],"Fever",[190,243],{"nctId":223,"briefTitle":224,"status":182,"phases":595,"primaryCompletion":226,"completion":226,"start":227,"enrollment":186,"conditions":596,"interventions":597},[54],[229],[219,166],{"nctId":232,"briefTitle":233,"status":234,"phases":599,"primaryCompletion":236,"completion":237,"start":238,"enrollment":239,"conditions":600,"interventions":601},[54],[241],[190,166,243],{"nctId":245,"briefTitle":246,"status":182,"phases":603,"primaryCompletion":248,"completion":249,"start":250,"enrollment":239,"conditions":604,"interventions":605},[54],[252],[190,166,243],{"nctId":607,"briefTitle":608,"status":234,"phases":609,"primaryCompletion":205,"completion":302,"start":184,"enrollment":186,"conditions":610,"interventions":611},"NCT02836509","Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department",[54],[217],[190,243],{"trials":613,"activeCount":9},[614],{"nctId":615,"briefTitle":616,"status":234,"phases":617,"primaryCompletion":618,"completion":618,"start":619,"enrollment":496,"conditions":620,"interventions":622},"NCT03697746","Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea",[55],"2019-04-01","2018-10-01",[621],"Dysmenorrhea",[219,623,243],"Dexketoprofen Trometamol",{"intervention":243,"totalTrials":19,"cells":625},{"EARLY_PHASE1":626,"PHASE1":628,"PHASE2":630,"PHASE3":632,"PHASE4":634,"NA":656},{"trials":627,"activeCount":9},[],{"trials":629,"activeCount":9},[],{"trials":631,"activeCount":9},[],{"trials":633,"activeCount":9},[],{"trials":635,"activeCount":9},[636,640,644,648,652],{"nctId":569,"briefTitle":570,"status":234,"phases":637,"primaryCompletion":572,"completion":184,"start":573,"enrollment":215,"conditions":638,"interventions":639},[54],[575],[219,243],{"nctId":586,"briefTitle":587,"status":182,"phases":641,"primaryCompletion":589,"completion":589,"start":590,"enrollment":186,"conditions":642,"interventions":643},[54],[592],[190,243],{"nctId":232,"briefTitle":233,"status":234,"phases":645,"primaryCompletion":236,"completion":237,"start":238,"enrollment":239,"conditions":646,"interventions":647},[54],[241],[190,166,243],{"nctId":245,"briefTitle":246,"status":182,"phases":649,"primaryCompletion":248,"completion":249,"start":250,"enrollment":239,"conditions":650,"interventions":651},[54],[252],[190,166,243],{"nctId":607,"briefTitle":608,"status":234,"phases":653,"primaryCompletion":205,"completion":302,"start":184,"enrollment":186,"conditions":654,"interventions":655},[54],[217],[190,243],{"trials":657,"activeCount":9},[658],{"nctId":615,"briefTitle":616,"status":234,"phases":659,"primaryCompletion":618,"completion":618,"start":619,"enrollment":496,"conditions":660,"interventions":661},[55],[621],[219,623,243],{"intervention":663,"totalTrials":58,"cells":664},"Magnesium Sulfate",{"EARLY_PHASE1":665,"PHASE1":667,"PHASE2":669,"PHASE3":671,"PHASE4":673,"NA":675},{"trials":666,"activeCount":9},[],{"trials":668,"activeCount":9},[],{"trials":670,"activeCount":9},[],{"trials":672,"activeCount":9},[],{"trials":674,"activeCount":9},[],{"trials":676,"activeCount":9},[677],{"nctId":678,"briefTitle":679,"status":182,"phases":680,"primaryCompletion":681,"completion":682,"start":683,"enrollment":684,"conditions":685,"interventions":687},"NCT05880732","Magnesium Sulfate on Postoperative Pain",[55],"2022-01-01","2022-03-01","2021-01-01",68,[686],"Postoperative Pain",[663,688],"normal saline isotonic solution",{"intervention":688,"totalTrials":58,"cells":690},{"EARLY_PHASE1":691,"PHASE1":693,"PHASE2":695,"PHASE3":697,"PHASE4":699,"NA":701},{"trials":692,"activeCount":9},[],{"trials":694,"activeCount":9},[],{"trials":696,"activeCount":9},[],{"trials":698,"activeCount":9},[],{"trials":700,"activeCount":9},[],{"trials":702,"activeCount":9},[703],{"nctId":678,"briefTitle":679,"status":182,"phases":704,"primaryCompletion":681,"completion":682,"start":683,"enrollment":684,"conditions":705,"interventions":706},[55],[686],[663,688],{"intervention":708,"totalTrials":58,"cells":709},"Intracochlear Dexamethasone",{"EARLY_PHASE1":710,"PHASE1":712,"PHASE2":714,"PHASE3":716,"PHASE4":718,"NA":720},{"trials":711,"activeCount":9},[],{"trials":713,"activeCount":9},[],{"trials":715,"activeCount":9},[],{"trials":717,"activeCount":9},[],{"trials":719,"activeCount":9},[],{"trials":721,"activeCount":9},[722],{"nctId":723,"briefTitle":724,"status":182,"phases":725,"primaryCompletion":726,"completion":727,"start":728,"enrollment":729,"conditions":730,"interventions":731},"NCT04397354","Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells",[55],"2022-08-01","2022-09-20","2020-03-02",34,[120],[708,732,733],"Intratympanic Dexamethasone","No additional drugs",{"intervention":732,"totalTrials":58,"cells":735},{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":737,"activeCount":9},[],{"trials":739,"activeCount":9},[],{"trials":741,"activeCount":9},[],{"trials":743,"activeCount":9},[],{"trials":745,"activeCount":9},[],{"trials":747,"activeCount":9},[748],{"nctId":723,"briefTitle":724,"status":182,"phases":749,"primaryCompletion":726,"completion":727,"start":728,"enrollment":729,"conditions":750,"interventions":751},[55],[120],[708,732,733],{"intervention":733,"totalTrials":58,"cells":753},{"EARLY_PHASE1":754,"PHASE1":756,"PHASE2":758,"PHASE3":760,"PHASE4":762,"NA":764},{"trials":755,"activeCount":9},[],{"trials":757,"activeCount":9},[],{"trials":759,"activeCount":9},[],{"trials":761,"activeCount":9},[],{"trials":763,"activeCount":9},[],{"trials":765,"activeCount":9},[766],{"nctId":723,"briefTitle":724,"status":182,"phases":767,"primaryCompletion":726,"completion":727,"start":728,"enrollment":729,"conditions":768,"interventions":769},[55],[120],[708,732,733],{"intervention":771,"totalTrials":58,"cells":772},"Lidocaine hydrochloride 2% with epinephrine 1:100 000",{"EARLY_PHASE1":773,"PHASE1":775,"PHASE2":777,"PHASE3":779,"PHASE4":781,"NA":783},{"trials":774,"activeCount":9},[],{"trials":776,"activeCount":9},[],{"trials":778,"activeCount":9},[],{"trials":780,"activeCount":9},[],{"trials":782,"activeCount":9},[],{"trials":784,"activeCount":9},[785],{"nctId":786,"briefTitle":787,"status":182,"phases":788,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":792,"interventions":797},"NCT07145879","Comparison of Postoperative Effects of Articaine and Lidocaine in Mucogingival Surgery",[55],"2025-07-30","2025-01-01",43,[793,794,795,796],"Local Analgesia Via Infiltration","Wound Heal","Pain, Postoperative","Hemorrhage",[771,798],"Articaine 4% with epinephrine 1:100,000",{"intervention":798,"totalTrials":58,"cells":800},{"EARLY_PHASE1":801,"PHASE1":803,"PHASE2":805,"PHASE3":807,"PHASE4":809,"NA":811},{"trials":802,"activeCount":9},[],{"trials":804,"activeCount":9},[],{"trials":806,"activeCount":9},[],{"trials":808,"activeCount":9},[],{"trials":810,"activeCount":9},[],{"trials":812,"activeCount":9},[813],{"nctId":786,"briefTitle":787,"status":182,"phases":814,"primaryCompletion":789,"completion":789,"start":790,"enrollment":791,"conditions":815,"interventions":816},[55],[793,794,795,796],[771,798],{"intervention":623,"totalTrials":58,"cells":818},{"EARLY_PHASE1":819,"PHASE1":821,"PHASE2":823,"PHASE3":825,"PHASE4":827,"NA":829},{"trials":820,"activeCount":9},[],{"trials":822,"activeCount":9},[],{"trials":824,"activeCount":9},[],{"trials":826,"activeCount":9},[],{"trials":828,"activeCount":9},[],{"trials":830,"activeCount":9},[831],{"nctId":615,"briefTitle":616,"status":234,"phases":832,"primaryCompletion":618,"completion":618,"start":619,"enrollment":496,"conditions":833,"interventions":834},[55],[621],[219,623,243],{"intervention":836,"totalTrials":58,"cells":837},"midazolam",{"EARLY_PHASE1":838,"PHASE1":840,"PHASE2":842,"PHASE3":844,"PHASE4":846,"NA":848},{"trials":839,"activeCount":9},[],{"trials":841,"activeCount":9},[],{"trials":843,"activeCount":9},[],{"trials":845,"activeCount":9},[],{"trials":847,"activeCount":9},[],{"trials":849,"activeCount":9},[850],{"nctId":851,"briefTitle":852,"status":182,"phases":853,"primaryCompletion":854,"completion":855,"start":854,"enrollment":856,"conditions":857,"interventions":859},"NCT01051271","Prophylaxis Against Metoclopramide-Induced Akathisia",[55],"2009-07","2009-11",225,[858],"Akathisia",[836],{"intervention":861,"totalTrials":58,"cells":862},"Lidocaine 2% Injectable Solution",{"EARLY_PHASE1":863,"PHASE1":865,"PHASE2":867,"PHASE3":869,"PHASE4":871,"NA":873},{"trials":864,"activeCount":9},[],{"trials":866,"activeCount":9},[],{"trials":868,"activeCount":9},[],{"trials":870,"activeCount":9},[],{"trials":872,"activeCount":9},[],{"trials":874,"activeCount":9},[875],{"nctId":876,"briefTitle":877,"status":234,"phases":878,"primaryCompletion":879,"completion":880,"start":881,"enrollment":882,"conditions":883,"interventions":886},"NCT05318560","Efficacy of Local Anesthetic and Ozone Injection in Patients With Myofascial Pain Syndrome",[55],"2022-09-10","2022-12-10","2022-06-30",72,[884,885],"Myofascial Pain Syndrome","Ozone",[861,885],{"intervention":885,"totalTrials":58,"cells":888},{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":899},{"trials":890,"activeCount":9},[],{"trials":892,"activeCount":9},[],{"trials":894,"activeCount":9},[],{"trials":896,"activeCount":9},[],{"trials":898,"activeCount":9},[],{"trials":900,"activeCount":9},[901],{"nctId":876,"briefTitle":877,"status":234,"phases":902,"primaryCompletion":879,"completion":880,"start":881,"enrollment":882,"conditions":903,"interventions":904},[55],[884,885],[861,885],{"intervention":906,"totalTrials":58,"cells":907},"Majezik %0.25 oral spray",{"EARLY_PHASE1":908,"PHASE1":910,"PHASE2":912,"PHASE3":914,"PHASE4":916,"NA":918},{"trials":909,"activeCount":9},[],{"trials":911,"activeCount":9},[],{"trials":913,"activeCount":9},[],{"trials":915,"activeCount":9},[],{"trials":917,"activeCount":9},[],{"trials":919,"activeCount":9},[920],{"nctId":921,"briefTitle":922,"status":182,"phases":923,"primaryCompletion":924,"completion":924,"start":925,"enrollment":140,"conditions":926,"interventions":929},"NCT05386667","Evaluation of the Effects of Medicaments Used After Free Gingival Graft on Postoperative Complications.",[],"2022-03-15","2019-03-05",[795,927,796,928],"Healing Wound","Analgesia",[906],{"intervention":931,"totalTrials":58,"cells":932},"Propofol group",{"EARLY_PHASE1":933,"PHASE1":935,"PHASE2":937,"PHASE3":939,"PHASE4":941,"NA":943},{"trials":934,"activeCount":9},[],{"trials":936,"activeCount":9},[],{"trials":938,"activeCount":9},[],{"trials":940,"activeCount":9},[],{"trials":942,"activeCount":9},[],{"trials":944,"activeCount":9},[945],{"nctId":946,"briefTitle":947,"status":182,"phases":948,"primaryCompletion":949,"completion":949,"start":950,"enrollment":951,"conditions":952,"interventions":954},"NCT06958913","Effect of Dexmedetomidine on Hemodynamics in Cardiac Surgery",[55],"2022-11-05","2022-05-05",52,[953],"Use of Dexmedetomidine in Cardiac Surgery (CABG, Valve Replacement or Total Aortic Arch Replacement)",[931,955],"Dexmedetomidine",{"intervention":955,"totalTrials":58,"cells":957},{"EARLY_PHASE1":958,"PHASE1":960,"PHASE2":962,"PHASE3":964,"PHASE4":966,"NA":968},{"trials":959,"activeCount":9},[],{"trials":961,"activeCount":9},[],{"trials":963,"activeCount":9},[],{"trials":965,"activeCount":9},[],{"trials":967,"activeCount":9},[],{"trials":969,"activeCount":9},[970],{"nctId":946,"briefTitle":947,"status":182,"phases":971,"primaryCompletion":949,"completion":949,"start":950,"enrollment":951,"conditions":972,"interventions":973},[55],[953],[931,955],{"intervention":975,"totalTrials":58,"cells":976},"metoclopramide 10 mg",{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":987},{"trials":978,"activeCount":9},[],{"trials":980,"activeCount":9},[],{"trials":982,"activeCount":9},[],{"trials":984,"activeCount":9},[],{"trials":986,"activeCount":9},[],{"trials":988,"activeCount":9},[989],{"nctId":990,"briefTitle":991,"status":182,"phases":992,"primaryCompletion":993,"completion":994,"start":993,"enrollment":995,"conditions":996,"interventions":997},"NCT01069536","Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide",[55],"2007-03","2008-05",140,[858,409],[975]]